Antifungal agent Bifonazole as an antiviral against SARS-CoV-2
In a recent study published in the journal Molecular Therapy, researchers identified Bifonazole, an imidazole-based antifungal agent, to have potent activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using high-throughput screening of small molecules.
United States Bifonazole Prestw American Society Of Gene Drug Administration Nanoluc Binary Technology Nanobi Molecular Therapy
Source: news-medical.net